Home / PEX7 Knockout Cell Lines

PEX7 Knockout Cell Lines

Gene: PEX7

Official Full Name: peroxisomal biogenesis factor 7provided by HGNC

Gene Summary: This gene encodes the cytosolic receptor for the set of peroxisomal matrix enzymes targeted to the organelle by the peroxisome targeting signal 2 (PTS2). Defects in this gene cause peroxisome biogenesis disorders (PBDs), which are characterized by multiple defects in peroxisome function. There are at least 14 complementation groups for PBDs, with more than one phenotype being observed in cases falling into particular complementation groups. Although the clinical features of PBD patients vary, cells from all PBD patients exhibit a defect in the import of one or more classes of peroxisomal matrix proteins into the organelle. Defects in this gene have been associated with PBD complementation group 11 (PBD-CG11) disorders, rhizomelic chondrodysplasia punctata type 1 (RCDP1), and Refsum disease (RD). [provided by RefSeq, Oct 2008]

Get A Quote
Products Background

Products

Catalog Number Product Name Species Gene Passage ratio Mycoplasma testing Price
KO36133 PEX7 Knockout cell line (HeLa) Human PEX7 1:3~1:6 Negative Online Inquiry
KO36134 PEX7 Knockout cell line (HCT 116) Human PEX7 1:2~1:4 Negative Online Inquiry
KO36135 PEX7 Knockout cell line (HEK293) Human PEX7 1:3~1:6 Negative Online Inquiry
KO36136 PEX7 Knockout cell line (A549) Human PEX7 1:3~1:4 Negative Online Inquiry

Background

PEX7 Gene Knockout Cell Lines are specialized cellular models engineered for the study of peroxisomal biogenesis and related metabolic disorders. These cell lines feature targeted disruptions of the PEX7 gene, which is essential for the proper functioning of peroxisomes—organelles critical for lipid metabolism and the detoxification of reactive oxygen species. By knocking out the PEX7 gene, researchers can create an in vitro environment that mimics peroxisomal dysfunction, enabling the detailed assessment of pathophysiological mechanisms and potential therapeutic strategies.

The primary mechanism of these knockout cell lines involves the absence of PEX7, disrupting the import of peroxisomal matrix enzymes, which impairs overall metabolic processes reliant on peroxisomes. This provides a valuable platform for studying disorders such as rhizomelic chondrodysplasia punctata and other peroxisomal biogenesis disorders. In clinical research and drug development, these cell lines facilitate high-throughput screening of compounds aimed at restoring peroxisome function or compensating for enzymatic deficiencies.

One of the significant advantages of using PEX7 Gene Knockout Cell Lines is their specificity and reliability compared to alternative models, such as primary cell cultures or less defined knockout systems. The consistent genetic background and well-characterized biological responses ensure reproducibility and robustness in experiments.

For researchers and clinicians, these cell lines not only expedite the understanding of metabolic pathways involved in peroxisomal function but also enhance the development of biotherapeutics and personalized medicine approaches. The ease of use with established cell culture techniques offers a streamlined process for experimental design and execution, thus making them an invaluable asset in laboratory settings.

Our company specializes in the production of high-quality, genetically engineered cell lines with rigorous validation processes, ensuring that our PEX7 Gene Knockout Cell Lines meet the highest standards of research excellence. With our commitment to advancing scientific discovery, we empower researchers to unlock new insights in the field of cell biology and metabolic diseases.

Please note that all services are for research use only. Not intended for any clinical use.

Get a free quote

If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.

0

There is no product in your cart.